Compare GROV & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GROV | ZTEK |
|---|---|---|
| Founded | 2016 | 2008 |
| Country | United States | Canada |
| Employees | 415 | N/A |
| Industry | Package Goods/Cosmetics | Major Chemicals |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 58.4M | 68.8M |
| IPO Year | N/A | 2022 |
| Metric | GROV | ZTEK |
|---|---|---|
| Price | $1.33 | $0.57 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $1.60 | N/A |
| AVG Volume (30 Days) | 89.8K | ★ 123.2K |
| Earning Date | 03-05-2026 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.81 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.02 | $0.54 |
| 52 Week High | $1.60 | $1.84 |
| Indicator | GROV | ZTEK |
|---|---|---|
| Relative Strength Index (RSI) | 48.38 | 35.38 |
| Support Level | $1.29 | $0.55 |
| Resistance Level | $1.35 | $0.75 |
| Average True Range (ATR) | 0.07 | 0.04 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 50.00 | 19.23 |
Grove Collaborative Holdings Inc is engaged in providing consumer products. It offers Cleaning accessories, Home and Pantry, Personal care products, Pets supplements and Other products. It is a sustainability oriented consumer products generator. It use connection with consumers to create and curate authentic, disruptive brands and products. Company builds natural products that perform as well as, many consumer packaged goods (CPG) brands (both conventional and natural), while being healthier for consumers and the planet.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.